A phase I clinical, pharmacokinetic study of ARQ 501 [beta-lapachone] in subjects with advanced solid tumours
Phase of Trial: Phase I
Latest Information Update: 20 Mar 2008
At a glance
- Drugs Beta lapachone (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 20 Mar 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov.
- 07 Aug 2006 Status change
- 19 Sep 2005 New trial record.